digestive system neoplasms
Showing 1 - 25 of 44
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01 in combination with standard adjuvant therapy)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01 in combination with standard adjuvant therapy
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Digestive System Tumors Trial in Hangzhou (iNeo-Vac-R01)
Recruiting
- Digestive System Neoplasms
- iNeo-Vac-R01
-
Hangzhou, Zhejiang, ChinaDepartment of General Surgery, Institute of Minimally Invasive S
Sep 8, 2023
Carcinoma, Intrahepatic Cholangiocarcinoma, Digestive System Tumors Trial in Guangzhou (Pemigatinib, PD-1 Inhibitors)
Recruiting
- Carcinoma
- +4 more
- Pemigatinib
- PD-1 Inhibitors
-
Guangzhou, Guangdong, ChinaLei Zhang
Jun 21, 2023
Esophageal Tumors, Esophageal Diseases, Digestive System Tumors Trial (Camrelizumab, Paclitaxel, Platinum)
Not yet recruiting
- Esophageal Neoplasms
- +2 more
- Camrelizumab
- +3 more
- (no location specified)
Nov 20, 2022
Stomach Tumors, Digestive System Tumors, Tumors Trial in Fuzhou (Camrelizumab, SOX, Surgery)
Active, not recruiting
- Stomach Neoplasms
- +5 more
- Camrelizumab
- +2 more
-
Fuzhou, Fujian, ChinaThe Second Affiliated Hospital of Fujian Medical University
Nov 1, 2022
Colorectal Cancer, RAS and BRAF Wild-type, Colorectal Tumors Trial in Hangzhou (Anlotinib Hydrochloride, Capecitabine,
Completed
- Colorectal Cancer
- +12 more
- Anlotinib Hydrochloride
- +2 more
-
Hangzhou, Zhejiang, China
- +1 more
Jul 12, 2022
Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Short free talk and relaxation)
Recruiting
- Digestive System Neoplasms
- Thoracic Neoplasms
- Emotional skills
- Short free talk and relaxation
-
Lille, FranceHôpital Calmette,CHU
Jul 4, 2022
Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)
Completed
- Neoplasms
- +14 more
- Entinostat
- Placebo
-
San Antonio, TexasThe START Center for Cancer Care
Apr 21, 2022
Palliative Primary Tumor Resection in Minimally Symptomatic
Recruiting
- Colorectal Neoplasms
- +12 more
- surgery of the primary tumour
- chemotherapy
-
Moscow, Russian FederationRyzhikh National Medical Research Center of Coloproctology
Apr 2, 2022
Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)
Recruiting
- Advanced Solid Tumors
- +3 more
- IM96 CAR-T cells
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Mar 10, 2022
Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- +10 more
- Anlotinib hydrochloride
- TQB2450
- (no location specified)
Feb 19, 2022
Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)
Completed
- Neoplasms
- +13 more
-
San Antonio, TexasThe START Center for Cancer Care
Jan 24, 2022
Carcinoma, Carcinoma, Hepatocellular, Liver Tumors Trial in Guangzhou (Hepatic arterial infusion chemo, Folfox Protocol,
Not yet recruiting
- Carcinoma
- +8 more
- Hepatic arterial infusion chemotherapy
- +2 more
-
Guangzhou, Guangdong, ChinaLei Zhang
Sep 22, 2021
Digestive System Tumors, Surgery, Surgery--Complications Trial in Rabat, Oujda
Terminated
- Digestive System Neoplasms
- +4 more
-
Rabat, Please Enter The State Or Province, Morocco
- +3 more
Sep 2, 2021
Digestive System Tumors Trial in Hong Kong (EUS-guided RFA)
Recruiting
- Digestive System Neoplasms
- EUS-guided RFA
-
Hong Kong, Hong KongDepartment of Surgery, Prince of Wales Hospital
Aug 2, 2021
Spanish Series of Patients Treated With Radionuclide Lutetium177
Recruiting
- Neuroendocrine Tumors
- +17 more
- Lutetium [177Lu] oxodotreotide/dotatate
-
Santiago De Compostela, A Coruña, Spain
- +18 more
Jul 1, 2021
Digestive System Tumors Trial in China (LP002, Cisplatin, Fluorouracil)
Unknown status
- Digestive System Neoplasms
- LP002
- +3 more
-
Beijing, Beijing, China
- +5 more
Feb 12, 2021
Digestive System Tumors Trial in Nanjing (Parenteral Nutrition)
Completed
- Digestive System Neoplasms
- Parenteral Nutrition
-
Nanjing, Jiangsu, ChinaJinlingH
Sep 26, 2020
Enteral Nutrition, Postoperative Period, Digestive System Tumors Trial in Nanjing (Enteral nutrition)
Completed
- Enteral Nutrition
- +2 more
- Enteral nutrition
-
Nanjing, Jiangsu, ChinaJinling Hospital, China
Sep 21, 2020
Hepatocellular Carcinoma, Liver Tumors, Digestive System Tumors Trial in Chengdu (TACE combined with sorafenib and PD-1 mAb)
Recruiting
- Hepatocellular Carcinoma
- +7 more
- TACE combined with sorafenib and PD-1 mAb
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital and Research Institute
Sep 14, 2020
Digestive System Tumors, Thoracic Tumors Trial in Lille (Emotional skills, Relaxation and talking group)
Terminated
- Digestive System Neoplasms
- Thoracic Neoplasms
- Emotional skills
- Relaxation and talking group
-
Lille, FranceHôpital Calmette,CHU
Sep 8, 2020
Stomach Tumors, Gastrointestinal Tumors, Stomach Diseases Trial (Apatinib, Capecitabine)
Not yet recruiting
- Stomach Neoplasms
- +7 more
- (no location specified)
Mar 23, 2019
Colorectal Tumors, Intestinal Tumors, Gastrointestinal Tumors Trial in Shenzhen (Apatinib Mesylate Tablets, Bevacizumab
Unknown status
- Colorectal Neoplasms
- +3 more
- Apatinib Mesylate Tablets
- Bevacizumab Injection
-
Shenzhen, Guang Dong, ChinaShenzhen People's Hospital
Jan 20, 2019